BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7886102)

  • 1. Continuous or intermittent cocaine administration: effects of flupenthixol treatment during withdrawal.
    King GR; Joyner C; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Dec; 49(4):883-9. PubMed ID: 7886102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous or intermittent cocaine administration: effects of amantadine treatment during withdrawal.
    King GR; Joyner C; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):451-7. PubMed ID: 8208762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent and continuous cocaine administration: residual behavioral states during withdrawal.
    King GR; Joyner C; Lee T; Kuhn C; Ellinwood EH
    Pharmacol Biochem Behav; 1992 Sep; 43(1):243-8. PubMed ID: 1409810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Withdrawal from continuous or intermittent cocaine: behavioral responsivity to 5-HT1 receptor agonists.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Jul; 45(3):577-87. PubMed ID: 8332619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine efflux during withdrawal from continuous or intermittent cocaine.
    King GR; Kuhn C; Ellinwood EH
    Psychopharmacology (Berl); 1993; 111(2):179-84. PubMed ID: 7870949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity to the locomotor depressant effect of a dopamine receptor antagonist during cocaine withdrawal in the rat.
    Baldo BA; Markou A; Koob GF
    Psychopharmacology (Berl); 1999 Jan; 141(2):135-44. PubMed ID: 9952037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of continuous cocaine dose, treatment, and withdrawal duration on the induction of behavioral tolerance and dopamine autoreceptor function.
    King GR; Hillburn C; Pinto G; Konen J
    Pharmacol Biochem Behav; 2004 Jun; 78(2):293-300. PubMed ID: 15219770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine.
    King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C
    Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute and chronic continuous methamphetamine have different long-term behavioral and neurochemical consequences.
    Davidson C; Lee TH; Ellinwood EH
    Neurochem Int; 2005 Feb; 46(3):189-203. PubMed ID: 15670635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ondansetron given in the acute withdrawal from a repeated cocaine sensitization dosing regimen reverses the expression of sensitization and inhibits self-administration.
    Davidson C; Lee TH; Xiong Z; Ellinwood EH
    Neuropsychopharmacology; 2002 Oct; 27(4):542-53. PubMed ID: 12377391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal from continuous or intermittent cocaine administration: changes in D2 receptor function.
    King GR; Ellinwood EH; Silvia C; Joyner CM; Xue Z; Caron MG; Lee TH
    J Pharmacol Exp Ther; 1994 May; 269(2):743-9. PubMed ID: 8182540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Betaxolol, a selective beta(1)-adrenergic receptor antagonist, diminishes anxiety-like behavior during early withdrawal from chronic cocaine administration in rats.
    Rudoy CA; Van Bockstaele EJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1119-29. PubMed ID: 17513029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of continuous cocaine duration on the induction of behavioral tolerance and dopamine autoreceptor function.
    King GR; Pinto G; Konen J; Hillburn C; Tran S; Love W; Cayse R; Castro G
    Eur J Pharmacol; 2002 Jun; 446(1-3):111-8. PubMed ID: 12098592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
    King GR; Xiong Z; Douglass S; Ellinwood EH
    Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT2 receptor antagonists given in the acute withdrawal from daily cocaine injections can reverse established sensitization.
    Davidson C; Lazarus C; Xiong X; Lee TH; Ellinwood EH
    Eur J Pharmacol; 2002 Oct; 453(2-3):255-63. PubMed ID: 12398913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient amelioration of the sensitization of cocaine-induced behaviors in rats by the induction of tolerance.
    Dalia AD; Norman MK; Tabet MR; Schlueter KT; Tsibulsky VL; Norman AB
    Brain Res; 1998 Jun; 797(1):29-34. PubMed ID: 9630493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal from continuous or intermittent cocaine: effects of NAN-190 on cocaine-induced locomotion.
    King GR; Joyner C; Lee TH; Ellinwood EH
    Pharmacol Biochem Behav; 1993 Feb; 44(2):253-62. PubMed ID: 8446658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.